Equity Method Investment - Additional Information (Details) - USD ($) $ in Millions |
3 Months Ended | ||
|---|---|---|---|
Jan. 25, 2024 |
Mar. 31, 2026 |
Jun. 30, 2026 |
|
| Equity Method Investment [Line Items] | |||
| Percentage of interest | 50.00% | ||
| AirJoule, LLC [Member] | |||
| Equity Method Investment [Line Items] | |||
| In-process research and development impairment | $ 110.3 | ||
| Goodwill impairment | 76.1 | ||
| Basis difference of goodwill impairment | $ 105.8 | $ 105.8 |
| X | ||||||||||
- Definition Basis difference of goodwill impairment. No definition available.
|
| X | ||||||||||
- Definition In Process Research And Development Impairment. No definition available.
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|